Moreover, in people with severe COVID-19 the infection reveals a diminished antiviral response marked by the downregulation of antiviral genes such as OAS1, SAMD9L and IFIT2, and suppression of antiviral immune response pathways48. The gene discussed is SAMD9L; the disease is COVID-19.